Renalytix

0 followers


Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.

Industries

Employees

51-200

Links

Org chart

James McCullough

Collapse
Steven Coca
Co-Founder
Michael J. Donovan
Chief Medical Officer
Jed Fulk
Vice President Of Sales
Anna Flynn
Director, Quality System Compliance And Eh&s
Elise Wilfinger
Chief Strategy & Marketing Officer
Katherine Edwards PhD
Senior R&d Scientist
Kate Brennan, CFA
Senior Manager, Strategic Finance
Christopher Scott
Chief Operating Officer